This site is intended for health professionals only
Saturday 1 October 2016 Instagram
Share |

Breast cancer trial could save £15m

Breast cancer trial could save £15m

A new technique to treat breast cancer means sufferers could be spared prolonged radiotherapy sessions.

Trials into the procedure, involving more than 2,000 women, saw patients receive a single dose of radiation targeting the precise site of their cancer.

The technique, called Targeted Intraoperative Radiotherapy (Targit), means patients do not have to undergo post-operation radiotherapy, which can include 20 or 30 trips to hospital over a period of five to six weeks.

It also reduces their exposure to radiation, with researchers hoping it could cut waiting lists and save the NHS up to £15 million every year.

Professor Jeffrey Tobias, from University College London Hospitals NHS Trust (UCLH), said: "I think the reason why it works so well is because of the precision of the treatment.

"It is given in a single dose via an intraoperative probe and the conventional surgery is extended by just 30-40 minutes while the patient is asleep under anaesthetic.

Josephine Ford, 80, who took part in the trial in 2008, said the treatment made the process "less traumatic".

She explained: "It made life so much easier and meant that I didn't have to come back to the radiotherapy department on a daily basis for five or six weeks."

Copyright © Press Association 2010

University College London Hospitals NHS Trust

Ads by Google

You are leaving

You are currently leaving the Nursing in Practice site. Are you sure you want to proceed?